Gryphon Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,765
Closed -$258K 269
2024
Q1
$258K Sell
4,765
-470
-9% -$23.9K 0.04% 224
2023
Q4
$280K Buy
5,235
+995
+23% +$52.2K 0.05% 196
2023
Q3
$246K Buy
4,240
+664
+19% +$40.7K 0.06% 160
2023
Q2
$229K Sell
3,576
-1,768
-33% -$119K 0.05% 176
2023
Q1
$370K Sell
5,344
-529
-9% -$37.3K 0.09% 131
2022
Q4
$423K Sell
5,873
-521
-8% -$39.3K 0.1% 112
2022
Q3
$454K Buy
6,394
+595
+10% +$43.2K 0.12% 101
2022
Q2
$447K Buy
5,799
+1,599
+38% +$122K 0.11% 107
2022
Q1
$307K Buy
4,200
+71
+2% +$4.77K 0.06% 156
2021
Q4
$257K Sell
4,129
-313
-7% -$18.4K 0.05% 176
2021
Q3
$262K Sell
4,442
-552
-11% -$36.4K 0.06% 168
2021
Q2
$321K Buy
4,994
+903
+22% +$58.9K 0.08% 136
2021
Q1
$257K Buy
4,091
+30
+0.7% +$1.87K 0.06% 147
2020
Q4
$252K Sell
4,061
-604
-13% -$37.1K 0.07% 136
2020
Q3
$282K Buy
+4,665
New +$281K 0.08% 124
2020
Q2
Sell
-4,626
Closed -$257K 138
2020
Q1
$257K Sell
4,626
-1,794
-28% -$110K 0.09% 118
2019
Q4
$412K Buy
+6,420
New +$368K 0.11% 108
2018
Q4
Sell
-5,892
Closed -$366K 196
2018
Q3
$366K Buy
5,892
+3,258
+124% +$193K 0.11% 97
2018
Q2
$146K Sell
2,634
-160
-6% -$8.64K 0.07% 102
2018
Q1
$177K Sell
2,794
-34
-1% -$2.19K 0.09% 86
2017
Q4
$173K Buy
+2,828
New +$177K 0.1% 91

Other funds holding BMY